Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Use of platelet‐rich plasma for COVID‐19–related olfactory loss: a randomized controlled trial
Introduction The current study evaluated the use of platelet‐rich plasma (PRP), an
autologous blood product with supraphysiologic concentrations of growth factors, in the …
autologous blood product with supraphysiologic concentrations of growth factors, in the …
The assessment of qualitative olfactory dysfunction in COVID-19 patients: a systematic review of tools and their content validity
Background There is a lack of overview of the tools used to assess qualitative olfactory
dysfunction, including parosmia and phantosmia, following COVID-19 illness. This could …
dysfunction, including parosmia and phantosmia, following COVID-19 illness. This could …
Long-term olfactory loss post-COVID-19: Pathobiology and potential therapeutic strategies
An acute loss of smell emerged as a striking symptom present in roughly half of the people
infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in …
infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in …
Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter …
Purpose Few evidence-based therapies are available for chronic olfactory dysfunction after
COVID-19. This study investigated the relative efficacy of olfactory training alone, co …
COVID-19. This study investigated the relative efficacy of olfactory training alone, co …
Development and psychometric validation of the olfactory dysfunction outcomes rating
Importance Olfactory dysfunction (OD) is an increasingly common and morbid condition,
especially given the ongoing COVID-19 pandemic. Thus, the ability to reproducibly measure …
especially given the ongoing COVID-19 pandemic. Thus, the ability to reproducibly measure …
A systematic review of the role of purinergic signalling pathway in the treatment of COVID-19
VG Korb, IC Schultz, LR Beckenkamp… - International Journal of …, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global health concern. Three years …
syndrome coronavirus 2 (SARS-CoV-2), has become a global health concern. Three years …
Post-COVID-19 anosmia and therapies: Stay tuned for new drugs to sniff out
Background: Anosmia is defined as the complete absence of olfactory function, which can
be caused by a variety of causes, with upper respiratory tract infections being among the …
be caused by a variety of causes, with upper respiratory tract infections being among the …
Evaluation of novel nasal mucoadhesive nanoformulations containing lipid-soluble EGCG for long COVID treatment
Following recovery from the acute infection stage of the SARS-CoV-2 virus (COVID-19),
survivors can experience a wide range of persistent Post-Acute Sequelae of COVID-19 …
survivors can experience a wide range of persistent Post-Acute Sequelae of COVID-19 …
[HTML][HTML] Delivery of topical drugs to the olfactory cleft
A Espehana, L Lee, EM Garden, G Klyvyte… - Journal of Clinical …, 2023 - mdpi.com
Olfactory dysfunction affects approximately 20% of the population globally, with incidence
increasing over the age of 60. The pathophysiology is complex, not yet fully understood, and …
increasing over the age of 60. The pathophysiology is complex, not yet fully understood, and …
A comprehensive review of COVID-19-related olfactory deficiency: unraveling associations with neurocognitive disorders and magnetic resonance imaging findings
Olfactory dysfunction (OD) is one of the most common symptoms in COVID-19 patients and
can impact patients' lives significantly. The aim of this review was to investigate the …
can impact patients' lives significantly. The aim of this review was to investigate the …